{"id":"W3205072810","doi":"10.1182/bloodadvances.2021004970","title":"Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Brentuximab vedotin; Internal medicine; Quality of life (healthcare); Oncology; Confidence interval; Classical Hodgkin lymphoma; Hazard ratio; Lymphoma; Hodgkin lymphoma; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001811648,0.0002178173,0.001255142,0.0002041406,0.00005655228,0.00001049356,0.0001048713,0.0001088488,0.0001118935],"category_scores_gemma":[0.0006345772,0.0001793892,0.0007187423,0.0006778063,0.0001239844,0.0001082719,0.00004841826,0.00004735678,0.000004305967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000726744,"about_ca_system_score_gemma":0.0004519381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004687491,"about_ca_topic_score_gemma":0.0001044383,"domain_scores_codex":[0.9979377,0.0001095478,0.0007867864,0.0004473527,0.0004437695,0.000274796],"domain_scores_gemma":[0.9977748,0.000804697,0.000428665,0.0005067993,0.0003065113,0.0001785431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004173208,0.02251132,0.835633,0.001305988,0.01335652,0.0001320567,0.0004190205,0.0001217341,0.009627427,0.008435084,0.0009230346,0.1033616],"study_design_scores_gemma":[0.03107246,0.001528674,0.8535773,0.0001988242,0.008406954,0.00001820165,0.0003992999,0.0001854524,0.06537295,0.0002688244,0.038661,0.0003101105],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819307,0.0150394,0.000187403,0.0007121557,0.0001713069,0.0002887699,0.0002212524,0.00003443598,0.001414541],"genre_scores_gemma":[0.9943419,0.001189466,0.003395497,0.0002633854,0.0001014335,0.00009037855,0.0002381191,0.00002159733,0.0003581929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1030515,"threshold_uncertainty_score":0.7315277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02921630299650604,"score_gpt":0.3286447617787381,"score_spread":0.299428458782232,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}